Top 5 Manufacturing Startup Investors in Pakistan in July 2025

Last updated: Jul 2025 A list of 5 angel investors and VC (Venture Capital) funds that invest in Manufacturing startups based in Pakistan. We rank investors based on the number of investments they made in Manufacturing companies from Pakistan. We update this investor list every month.

Top 5 Manufacturing Startup Investors in Pakistan in July 2025

Investor	Manufacturing Pakistan investments
U.S. Venture Partners	2
Technology Partners	1
Storm Ventures	1
Christopher Rust	1
Clear Ventures	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

U.S. Venture Partners (USVP) is a venture capital partnership, helping entrepreneurs transform their ideas and efforts into world-changing companies. The firm focuses on early-stage ventures in information technology and health care, where innovation is unbridled and has led to the creation of economic wealth and millions of jobs over the pastthirty-plus years of the firm's existence. Areas of particular interest to our investment professionals include enterprise software, IT security, consumer internet, mobile, and e-commerce, healthcare, and IT-enabled healthcare services. The USVP team consists of former entrepreneurs, technologists, corporate executives, financial professionals, and industry domain experts.

Investment focus

Software, Health Care, Information Technology
Series B, Series C, Series A
United States, Israel, Canada

Portfolio highlights

Clarify AI — Clarify is an AI-powered writing tool that accelerates the academic writing process.
Clarify — Clarify consolidates your customer data into one platform, streamlining collaboration and unifying teams around their customer.
Neuros Medical — Neuros Medical is a neuromodulation company, is focused on developing proprietary therapies for the unmet needs of patients worldwide. The Company's patented platform technology, Electrical Nerve Block, is focused on the elimination of chronic pain in a variety of applications including neuroma/residual limb pain, chronic post-surgicalpain, and chronic migraine.

Technology Partners is a venture capital firm specialized in seed-, early-, and later-stage venture and private equity investments.

Investment focus

Health Care, Biotechnology, Medical
Series B, Series C, Funding Round
United States, Pakistan

Portfolio highlights

Beamreach — Beamreach Solar is developing high-efficiency, low-cost, crystalline silicon solar cells and modules for photovoltaic (PV) electricity generation.
Benvenue Medical — Benvenue Medical, Inc. is developing innovative, minimally invasive surgical solutions to treat spinal disorders. The company is privately held and funded by CRG Partners.
Elcelyx Therapeutics — Elcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx’s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMetfor Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market.Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.Elcelyx is headquartered in San Diego, California.

Storm Ventures is a $600m (TAM) VC firm 100% focused solely on early-stage enterprise investments. We've been founders ourselves, of enterprise companies including Airespace (acquired by Cisco) and EchoSign (acquired by Adobe). We've had to go without pay as CEOs ourselves to make payroll. We've gone from $0 to $100m in ARR andlived all the stages in between. We've here to help, and add some strategic capital and insights. And not be in the way when we're not needed.